Biological E Limited on Saturday announced that its COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous booster dose. A press release from the......
Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which......
Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of......
By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.The vaccine, named PTX-COVID19-B, is under development in Canada and......
Providence will sell up to 30 mn doses of its mRNA vaccine to Biological E. It would also provide the necessary technology transfer to make the vaccine in India, with a minimum production capacity......
The collective wealth of the 100 richest went past $1 trillion for the first time. IMAGE: Mukesh Ambani, chairman and managing director of Reliance Industries, left, has once again secured top......
Microsoft co-founder Bill Gates visited Biological E Ltd, a city-based vaccine manufacturer, late in the evening on Thursday.Gates who is also Co-Chair of the Bill and Melinda Gates Foundation,......
Indian vaccine companies may lose the pricing edge as the imminent entry of Chinese companies is likely to change the supply landscape in the world, according to Mahima Datla, senior vice-president......